-

American Healthcare REIT Announces Dates for Second Quarter 2026 Earnings Release and Conference Call

IRVINE, Calif.--(BUSINESS WIRE)--American Healthcare REIT, Inc. (the “Company”) (NYSE: AHR) announced today that it will issue its second quarter 2026 earnings release on Thursday, August 6, 2026, after the close of trading.

A public conference call with a simultaneous webcast will be held on Friday, August 7, 2026, at 10:00 a.m. Pacific Time / 1:00 p.m. Eastern Time. During the conference call, company executives will review second quarter 2026 results, discuss recent events, and conduct a question-and-answer period.

To join via webcast, investors may use the following link: https://events.q4inc.com/attendee/449803626

To join the live telephone conference call, please dial one of the following numbers at least five minutes prior to the start time:

North America Toll-Free: +1 833-461-5787
International Toll: +1 585-542-9983
International Dial-Ins: https://help.events.q4inc.com/eahc/international-dial-in-numbers
Meeting ID: 449 803 626

A digital replay of the call will be available in the Investor Relations section of the Company’s website at https://ir.americanhealthcarereit.com shortly after the conclusion of the call. The full text of the earnings report and supplemental data will be available immediately following the earnings release to the wire services on August 6, 2026, in the Investor Relations section of the Company’s website at https://ir.americanhealthcarereit.com.

About American Healthcare REIT, Inc.

American Healthcare REIT, Inc. (NYSE: AHR) is a real estate investment trust that acquires, owns and operates a diversified portfolio of clinical healthcare real estate, focusing primarily on senior housing communities, skilled nursing facilities, and outpatient medical buildings across the United States, and in the United Kingdom and the Isle of Man.

SOURCE American Healthcare REIT, Inc.

Contacts

Investor Contact:
Alan Peterson
VP, Investor Relations & Finance
(949) 270-9200
investorrelations@ahcreit.com

Media Contact:
Damon Elder
Spotlight Marketing Communications
(949) 427-1377
damon@spotlightmarcom.com

American Healthcare REIT, Inc.

NYSE:AHR

Release Versions

Contacts

Investor Contact:
Alan Peterson
VP, Investor Relations & Finance
(949) 270-9200
investorrelations@ahcreit.com

Media Contact:
Damon Elder
Spotlight Marketing Communications
(949) 427-1377
damon@spotlightmarcom.com

Social Media Profiles
More News From American Healthcare REIT, Inc.

American Healthcare REIT Announces Pricing of Public Offering of Common Stock

IRVINE, Calif.--(BUSINESS WIRE)--American Healthcare REIT, Inc. (NYSE: AHR; the “Company”) announced today the pricing of an underwritten public offering of 13,250,000 shares of its common stock, all of which are being offered in connection with the forward sale agreements described below. The aggregate gross proceeds to the Company from the offering, before deducting estimated offering expenses, are expected to be approximately $712.2 million. The offering is expected to close August 12, 2026,...

American Healthcare REIT Announces Public Offering of Common Stock

IRVINE, Calif.--(BUSINESS WIRE)--American Healthcare REIT, Inc. (NYSE: AHR; the “Company”) announced today that it has commenced an underwritten public offering of 13,250,000 shares of its common stock on a forward basis in connection with the forward sale agreements described below. Morgan Stanley, Citigroup and KeyBanc Capital Markets are acting as the joint book-running managers for the offering. In connection with the offering, the Company expects to enter into forward sale agreements with...

American Healthcare REIT Announces Second Quarter 2026 Results; Increases Full Year 2026 Guidance

IRVINE, Calif.--(BUSINESS WIRE)--American Healthcare REIT, Inc. (NYSE: AHR) (the “Company,” “we,” “our,” “us,” “management,” or "AHR") is announcing today its second quarter 2026 results and increasing full year 2026 guidance. Key Highlights: Reported GAAP net income attributable to controlling interest of $30.6 million, or $0.16 per diluted share, for the three months ended June 30, 2026. Reported Normalized Funds From Operations attributable to controlling interest (“NFFO”) of $0.54 per dilut...
Back to Newsroom